The , a new once-daily combination serdexmethylphenidate and immediate-release d-methylphenidate stimulant medication, for ADHD in patients ages 6 and older, KemPharm announced.
Should get a moniker overhaul? (Scientific American)
Monitoring dynamic changes in was better at predicting post-discharge suicide attempts than only using baseline admission data. (JAMA Network Open)
Could the also relieve depression and anhedonia? (American Journal of Psychiatry)
Sustaining just can increase one's risk of dementia decades later. (Alzheimer's & Dementia)
A new study pinpointed a link between . (Gizmodo)
Meghan Markle, in an interview with Oprah Winfrey, opened up about her struggle with suicidal thoughts. (鶹ý)
in its quest to have approved for dementia-related psychosis hallucinations and delusions -- the FDA faulted the firm's application for "deficiencies that preclude discussion of labeling and post-marketing requirements/commitments at this time."
![author['full_name']](https://clf1.medpagetoday.com/media/images/author/kristenMonaco_188.jpg)